- Filed
- Apr 29, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 16.26M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $281.6M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $281.6M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $44M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $79.6M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $300.2M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $320.4M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $797.3M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $824.7M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $499.6M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $545.4M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.63B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.68B |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $500K |
| Capex | Q1 2025 · Mar 31, 2024 | $18.5M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $59.2M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $684.5M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $668.8M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $1.03 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.03 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $28.1M |
| Net Income | Q1 2025 · Mar 31, 2024 | $17.2M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$800K |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $225.5M |